Sarissa Capital Acquisition Corp.

Sarissa Capital Acquisition Corp. (Nasdaq: SRSA) is a blank-check company sponsored by Sarissa Capital Management, the healthcare-focused activist investment firm led by Alex Denner. The SPAC completed its initial public offering in 2021, targeting opportunities in the biopharmaceutical and life sciences sector. As of its 10-Q filing with the SEC on August 12, 2022, SRSA remained in its search phase, continuing to evaluate potential business combination targets within its stated healthcare focus. Sarissa Capital Management's background in concentrated biopharmaceutical activism distinguishes SRSA from more generalist healthcare SPACs in the market. Sign up at SpacDesk for full filings, timeline data, and deal analytics on SRSA and the broader SPAC universe.